Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DMNTELW)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
1-Benzyl-4-phenylpiperidin-4-ol; 63843-83-4; 1-Benzyl-4-phenyl-4-piperidinol; 4-Piperidinol, 1-benzyl-4-phenyl-; 1-Benzyl-4-phenyl-piperidin-4-ol; EINECS 264-512-8; 1-benzyl-4-hydroxy-4-phenylpiperidine; 1-benzyl-4-hydroxy-4-phenyl piperidine; BRN 0235839; CHEMBL230141; F1446-0078; NSC116051; AC1L3YAO; Oprea1_213406; Oprea1_173104; SCHEMBL1411499; AC1Q7B56; CTK5B9985; DTXSID60213290; MolPort-001-954-320; FCLMXEAPEVBCKQ-UHFFFAOYSA-N; ZINC320034; HMS1672E06; BCP13431; ANW-45516; BDBM50210409; STK081775; AKOS000541462
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs
|
||||||||||||||||||||||||||
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||